• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19 Back to Search Results
Model Number HL-CR4-01-000
Device Problem Defective Component (2292)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/26/2020
Event Type  malfunction  
Manufacturer Narrative
Alung technologies, inc.Manufactures the hemolung ras and catheter.The incident occurred in (b)(4), united kingdom.Shortly following initiation of hemolung therapy, the controller alarmed with elevated cabinet o2.O2 was running as sweep gas.The staff was advised to switch to using air for the sweep gas, which resolved the issue.However, four hours later hemolung therapy was attempted to return to o2 for the sweep gas as the patient was hypoxic.But the controller began again alarming with elevated cabinet o2.Support was provided in which the staff was advised to continue hemolung therapy with room air as the sweep gas.The data log was retrieved and reviewed by both clinical and software engineering staff.The software engineering review suggest a possible leak in the vacuum pump / sweep gas module, as opposed to a faulty o2 sensor.The controller was exchanged and repaired.The clinical review shows no abnormalities were noted within the co2 removal and blood flow graphs.Hemolung therapy was provided as intended.No capa was opened because of this event.Alung technologies, inc.Will continue to monitor any issues as they are reported.This mdr is being filed in response to a retrospective view of all alung technologies, inc.Complaints, which identified that the reporting decision for this complaint was not correct.This mdr is being filed retrospectively to correct the error in the reporting decision.
 
Event Description
Alung technologies, inc.Received a report shortly after hemolung therapy started the hemolung device started alarming 'high cabinet o2 levels'.O2 was running as sweep gas.The site was advised by support to continue hemolung therapy with room air as the sweep gas.There was no report of patient injury because of this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOLUNG RAS
Type of Device
EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19
Manufacturer (Section D)
ALUNG TECHNOLOGIES, INC.
2500 jane st
suite 1
pittsburgh PA 15203
Manufacturer Contact
ryan coyle
2500 jane st
suite 1
pittsburgh, PA 15203
MDR Report Key16200023
MDR Text Key308975209
Report Number3009763347-2023-00055
Device Sequence Number1
Product Code QLN
UDI-Device Identifier00850046004346
UDI-Public(01)00850046004346(17)171102
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
DEN210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Remedial Action Repair
Type of Report Initial
Report Date 01/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberHL-CR4-01-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/26/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-